bpc 157 interactions with supplements The Human Lab Rats Injecting Themselves Peptides | Office for Science and Society The Hidden Risks of BPC‑157:

Investigated as a safer alternative to HGH without impacting blood sugar or IGF-1 pathways

[7] [9] Use is also contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as high doses of ascorbic acid may induce hemolysis in this population

Protocol Used: 0.25 mg BPC-157 subcutaneous injection daily for 6 weeks, administered 2 inches proximal to Achilles insertion point, combined with eccentric heel drops and gradual return to running

Signs include hives, swelling of the lips, tongue, or face, and severe dizziness

Administration preference influences adherence

In terms of conclusions about human health, without randomised controlled clinical trials in humans, its very difficult to draw firm conclusions at all